Literature DB >> 2360831

Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.

A Brisson-Noël1, S Dutka-Malen, C Molinas, R Leclercq, P Courvalin.   

Abstract

Fragments of plasmid pIP816, which confers high-level glycopeptide resistance in Enterococcus faecium BM4147, were cloned into a conjugative gram-negative-gram-positive shuttle vector. The resulting hybrids were transferred by conjugation from Escherichia coli to Enterococcus faecalis and Bacillus thuringiensis. A 4-kilobase EcoRI fragment from pIP816 was found to confer vancomycin resistance in these hosts but not in E. coli or Bacillus subtilis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360831      PMCID: PMC171723          DOI: 10.1128/AAC.34.5.924

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

2.  Vancomycin-resistant leuconostocs, lactobacilli and now pediococci.

Authors:  G Colman; A Efstratiou
Journal:  J Hosp Infect       Date:  1987-07       Impact factor: 3.926

3.  Teicoplanin-resistant coagulase-negative staphylococci.

Authors:  V Arioli; R Pallanza
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

4.  Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; S J Hobbs
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

5.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.

Authors:  D M Shlaes; A Bouvet; C Devine; J H Shlaes; S al-Obeid; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

6.  Vancomycin therapy in severe staphylococcal infections.

Authors:  W M Kirby
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

7.  Vancomycin therapy for infective endocarditis.

Authors:  J E Geraci; W R Wilson
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

8.  The antibacterial action of vancomycin.

Authors:  C Watanakunakorn
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

9.  Vancomycin-resistant streptococci or Leuconostoc sp.

Authors:  A Buu-Hoï; C Branger; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

10.  Vancomycin for treatment of bacterial meningitis.

Authors:  D W Gump
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec
View more
  23 in total

1.  The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes.

Authors:  S Dutka-Malen; C Molinas; M Arthur; P Courvalin
Journal:  Mol Gen Genet       Date:  1990-12

Review 2.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  Conjugative transposition of Tn916 requires the excisive and integrative activities of the transposon-encoded integrase.

Authors:  M J Storrs; C Poyart-Salmeron; P Trieu-Cuot; P Courvalin
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

4.  Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.

Authors:  S Dutka-Malen; R Leclercq; V Coutant; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

5.  [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].

Authors:  R-P Vonberg; I F Chaberny; A Kola; F Mattner; S Borgmann; M Dettenkofer; D Jonas; A-M Fahr; I Klare; G Werner; K Weist; C Wendt; P Gastmeier
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

Review 6.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB.

Authors:  M K Hayden; R N Picken; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

8.  Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.

Authors:  M Green; B Binczewski; A W Pasculle; M Edmund; K Barbadora; S Kusne; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.

Authors:  H S Gold; S Unal; E Cercenado; C Thauvin-Eliopoulos; G M Eliopoulos; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans.

Authors:  M Ligozzi; G Lo Cascio; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.